Interplay Between PCBP2 and Mirna Modulates ARHGDIA Expression and Function in Glioma Migration and Invasion

Xihua Lin,Bin Yang,Wei Liu,Xiaochao Tan,Fan Wu,Peishan Hu,Tao Jiang,Zhaoshi Bao,Jiangang Yuan,Boqin Qiang,Xiaozhong Peng,Wei Han
DOI: https://doi.org/10.18632/oncotarget.6869
2016-01-01
Oncotarget
Abstract:RNA-RNA and protein-RNA interactions are essential for post-transcriptional regulationin normal development and may be deregulated in cancer initiation and progression. The RNA-binding protein PCBP2, an oncogenic protein in human malignant gliomas, is an essential regulator of mRNA and miRNA biogenesis, stability and activity. Here, we identified Rho GDP dissociation inhibitor α (ARHGDIA) as a target mRNA that binds to PCBP2, and we uncovered the role of ARHGDIA as a putative metastasis suppressor through analyses of in vitro and in vivo models of EMT and metastasis. Furthermore, we demonstrated that ARHGDIA is a potential target of miR-151-5p and miR-16 in gliomas. The interaction between PCBP2 and the 3′UTR of the ARHGDIA mRNA may induce a local change in RNA structure that favors subsequent binding of miR-151-5p and miR-16, thus leading to the suppression of ARHGDIA expression. PCBP2 may facilitate miR-151-5p and miR-16 promotion of glioma cell migration and invasion through mitigating the function of ARHGDIA.
What problem does this paper attempt to address?